Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Gross Profit
Abbott Laboratories
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Gross Profit
$22.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Gross Profit
$8.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
Boston Scientific Corp
NYSE:BSX
|
Gross Profit
$9.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Gross Profit
$4.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
12%
|
|
Stryker Corp
NYSE:SYK
|
Gross Profit
$13.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Gross Profit
$4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
13%
|
See Also
What is Abbott Laboratories's Gross Profit?
Gross Profit
22.3B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Gross Profit amounts to 22.3B USD.
What is Abbott Laboratories's Gross Profit growth rate?
Gross Profit CAGR 10Y
8%
Over the last year, the Gross Profit growth was -3%. The average annual Gross Profit growth rates for Abbott Laboratories have been 2% over the past three years , 4% over the past five years , and 8% over the past ten years .